Jump to main content
Jump to site search

Issue 5, 2016
Previous Article Next Article

Copper(II) quinolinonato-7-carboxamido complexes as potent antitumor agents with broad spectra and selective effects

Author affiliations

Abstract

A series of five copper(II) mixed-ligand complexes with the composition [Cu(quix)(phen)]NO3·yH2O (1 to 5), where Hquix stands for 2-(4-amino-3,5-dichlorophenyl)-3-hydroxy-4(1H)-quinolinone-7-carboxamides with different N-substitutions: Hqui1 = N-propyl (1), Hqui2 = N-isobutyl (2), Hqui3 = N-cyclohexyl (3), Hqui4 = N-benzyl (4), and Hqui5 = N-p-xylyl (5); phen = 1,10-phenanthroline and y = 0 or 1, were synthesized, characterized and screened for in vitro antitumor activity on a panel of six human cancer cell lines, including osteosarcoma (HOS), breast adenocarcinoma (MCF7), malignant melanoma (G361), cervix carcinoma (HeLa), ovarian carcinoma (A2780) and cisplatin-resistant ovarian carcinoma (A2780R). All the complexes, except for limitedly soluble complex 4, showed very potent cytotoxicity (IC50 ≈ 1–7 μM); the best IC50 value was found for complex 5 against A2780, with IC50 = 0.6(1) μM. Moreover, complex 5 was found to be non-toxic up to 50 μM against non-malignant lung fibroblast cells (MRC-5); therefore, showing a promising selectivity index [IC50(MRC-5)/IC50(A2780)] that was higher than 80. The complexes were also shown to bind to calf thymus DNA, interact with physiological levels of L-cysteine and act as chemical nucleases. It was additionally suggested that the species responsible for the biological activities of the prepared complexes were the [Cu(qui)(phen)]+ cations, or similar cationic species containing the {Cu(phen)} residue. The results clearly demonstrated that targeted structural optimization of the quinolinonato ligand in this class of complexes leads to compounds with high-level and broad-spectrum anticancer activity along with significantly increased selectivity.

Graphical abstract: Copper(ii) quinolinonato-7-carboxamido complexes as potent antitumor agents with broad spectra and selective effects

Back to tab navigation

Supplementary files

Publication details

The article was received on 22 Oct 2015, accepted on 10 Dec 2015 and first published on 14 Dec 2015


Article type: Paper
DOI: 10.1039/C5RA22141B
Citation: RSC Adv., 2016,6, 3899-3909
  • Open access: Creative Commons BY-NC license
  •   Request permissions

    Copper(II) quinolinonato-7-carboxamido complexes as potent antitumor agents with broad spectra and selective effects

    R. Křikavová, J. Vančo, Z. Trávníček, R. Buchtík and Z. Dvořák, RSC Adv., 2016, 6, 3899
    DOI: 10.1039/C5RA22141B

    This article is licensed under a Creative Commons Attribution-NonCommercial 3.0 Unported Licence. Material from this article can be used in other publications provided that the correct acknowledgement is given with the reproduced material and it is not used for commercial purposes.

    Reproduced material should be attributed as follows:

    • For reproduction of material from NJC:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the Centre National de la Recherche Scientifique (CNRS) and the RSC.
    • For reproduction of material from PCCP:
      [Original citation] - Published by the PCCP Owner Societies.
    • For reproduction of material from PPS:
      [Original citation] - Published by The Royal Society of Chemistry (RSC) on behalf of the European Society for Photobiology, the European Photochemistry Association, and RSC.
    • For reproduction of material from all other RSC journals:
      [Original citation] - Published by The Royal Society of Chemistry.

    Information about reproducing material from RSC articles with different licences is available on our Permission Requests page.

Search articles by author

Spotlight

Advertisements